Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
KeyMed Biosciences Inc banner
K

KeyMed Biosciences Inc
F:64Z

Watchlist Manager
KeyMed Biosciences Inc
F:64Z
Watchlist
Price: 8.05 EUR -0.62%
Market Cap: €2.2B
Write Note Create Alert Ask AI

Wall St Price Targets

64Z Price Targets Summary
KeyMed Biosciences Inc

Wall Street analysts forecast 64Z stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 64Z is 9.28 EUR with a low forecast of 7.46 EUR and a high forecast of 11.07 EUR.

64Z Lowest Forecast
Wall Street Target
€7.46
-7% Downside
64Z Average Forecast
Wall Street Target
€9.28
15% Upside
64Z Highest Forecast
Wall Street Target
€11.07
38% Upside
Lowest Forecast
Price Target
7.46 EUR
7% Downside
Average Forecast
Price Target
9.28 EUR
15% Upside
Highest Forecast
Price Target
11.07 EUR
38% Upside
KeyMed Biosciences Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 7 years is 31%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Gross Profit over the next 3 years is 46%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
25%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
25%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

What are analyst estimates?

Continue 64Z Research

Summary
64Z intrinsic value, competitors valuation, and company profile.
DCF Valuation
64Z stock valuation using Discount Cash Flow valuation method.
Relative Valuation
64Z stock valuation using valuation multiples.
Wall St Estimates
64Z price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
64Z stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other KeyMed Biosciences Inc listings:
HKEX • HKD
2162
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 64Z's stock price target?
Price Target
9.28 EUR

According to Wall Street analysts, the average 1-year price target for 64Z is 9.28 EUR with a low forecast of 7.46 EUR and a high forecast of 11.07 EUR.

What is the Revenue forecast for KeyMed Biosciences Inc?
Projected CAGR
31%

The compound annual growth rate for Revenue over the next 7 years is 31%.

What is the Gross Profit forecast for KeyMed Biosciences Inc?
Projected CAGR
46%

The compound annual growth rate for Gross Profit over the next 3 years is 46%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.